We are proud to celebrate the scientific achievements of our researchers and trainees in publications, grant competitions, honors and awards, and appointments, as well as in the mainstream press.

The Cancer Research Program (CRP) organizes and supports numerous speakers, seminars, and symposia throughout the year.

The Women's Health Research Unit (WHRU) conducts research in women's health and gynecology, specializing in gynecological oncology. Its DOvEE research clinic ensures that eligible women are offered easy, fast access to specialized medical examinations for the early detection and diagnosis of ovarian and endometrial cancers.

The Terry Fox Research Institute brings together RI-MUHC and other Canadian researchers in multiple joint projects, including the Canadian Ovarian Experimental Unified Resource (COEUR) for biomarker research in ovarian cancer, the Enhanced pancreatic cancer profiling for individualized care (EPPIC) and a project to study metastatic sarcomas.

The McGill University Thoracic and Upper GI Cancer Research Laboratories investigate the cellular, molecular, and genetic determinants of cancer metastasis from lung, esophageal and gastric malignancies.

Opal is an innovative mobile phone application that strives to make oncology patients' lives better. The app is also being tested at the Montreal Children’s Hospital.

The Quebec SmartCare Consortium, led by the Opal Health Informatics Group, brings together public and private healthcare organizations with the goal of demonstrating the efficiency of a solution to digitize all healthcare interactions and make all personal healthcare data accessible to patients by 2030.

The Cellular Therapy Laboratory (CTL) at the RI-MUHC enhances research capabilities using stem cells. The CTL collects and stores cells and tissues, provides screening services, undertakes fundamental research, adapts findings for clinical use, and participates in clinical trials.

The Centre for Applied Nanomedicine (CAN) at the RI-MUHC is a specialized technology platform and research hub for studies on extracellular vesicles (EVs) and nanosized extracellular particles (EPs).

The Rossy Cancer Network is a partnership of McGill's Faculty of Medicine, St. Mary’s Hospital, Jewish General Hospital and the McGill University Health Centre with a mission to improve cancer care quality.

The Henry C. Witelson Ocular Pathology Laboratory brings together clinicians and researchers to discover the mechanisms underlying various ocular diseases including uveal melanoma, retinoblastoma and other clinical ocular pathologies.

The Clinical Research Organization in Cancer (Q-CROC) coordinates a network of 16 of the most active health care institutions in oncology clinical research, accounting for more than 98% of recruiting studies in the province. The network has more than 250 investigators and 500 research professionals.

The Program for Women’s cancer Research (PWR) in radiation oncology conducts research in the areas of gynecological and breast malignancies. PWR aims to bring new and innovative treatments and technologies into clinical practice, to reduce side effects and improve cure rates for patients with these cancers.